1. Home
  2. TARS vs NP Comparison

TARS vs NP Comparison

Compare TARS & NP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$65.11

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

NP

Neptune Insurance Holdings Inc.

N/A

Current Price

$28.02

Market Cap

2.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TARS
NP
Founded
2016
2017
Country
United States
United States
Employees
N/A
58
Industry
Medicinal Chemicals and Botanical Products
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TARS
NP
Price
$65.11
$28.02
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$89.00
$28.17
AVG Volume (30 Days)
595.9K
376.6K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
48.21
N/A
EPS
N/A
N/A
Revenue
$451,360,000.00
N/A
Revenue This Year
$56.43
$25.84
Revenue Next Year
$30.19
$15.80
P/E Ratio
N/A
N/A
Revenue Growth
146.71
N/A
52 Week Low
$38.51
$14.78
52 Week High
$85.25
$31.75

Technical Indicators

Market Signals
Indicator
TARS
NP
Relative Strength Index (RSI) 51.22 55.64
Support Level $61.24 $23.60
Resistance Level $67.24 $29.25
Average True Range (ATR) 3.59 1.75
MACD 0.09 0.17
Stochastic Oscillator 81.30 59.60

Price Performance

Historical Comparison
TARS
NP

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

About NP Neptune Insurance Holdings Inc.

Neptune Insurance Holdings Inc is a high-growth, data-driven MGA that is revolutionizing the way homeowners and businesses protect against the growing risks of flooding. It offers a range of easy-to-purchase residential and commercial insurance products - including primary flood insurance, excess flood insurance, and parametric earthquake insurance - distributed through a nationwide network of agencies. It underwrites and administers the issuance of insurance policies on behalf of a diverse panel of insurance and reinsurance companies, whom the company refer to as capacity providers, that manage both this risk and the associated claims handling.

Share on Social Networks: